Weekly Roundup - PHARMA - 20 January 2025 🔊Autolus Therapeutics Secures FDA Approval for Aucatzyl Cell Therapy in Relapsed B-Cell Leukemia Autolus Therapeutics is launching Aucatzyl commercially in the U.S.

🚀 Weekly Roundup - PHARMA - 20 January 2025

www.linkedin.com/pulse/weekly...

kstrategyand.com/pharma-news

#AutolusTherapeutics #BannerLifeSciences #Bafiertam #Pfizer #Sasanlimab #TyraBiosciences #ImmunoForge #Pemziviptadil #PharmaNews #ClinicalTrials #Humanteconomy #Humantec #KStrategyand